Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huatai Financial Holdings (Hong Kong) Limited is the international flagship of Huatai Securities, one of China's largest and most prominent integrated securities groups. The firm provides a comprehensive suite of financial services, including investment banking, asset management, and wealth management, to a global clientele. While not a biotechnology developer itself, Huatai is a critical player in the life sciences ecosystem, serving as a leading financier and advisor for healthcare companies. The company is particularly recognized for its expertise in facilitating IPOs for biotech firms on the Hong Kong Stock Exchange, especially under the Chapter 18A listing rules. Through its dedicated healthcare investment banking and private equity arms, Huatai supports the growth of innovative companies in the pharmaceutical, medical device, and digital health sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huatai Financial Holdings.